• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

逃避人源单克隆抗体中和作用影响严重急性呼吸综合征冠状病毒的体外和体内适应性。

Escape from human monoclonal antibody neutralization affects in vitro and in vivo fitness of severe acute respiratory syndrome coronavirus.

机构信息

Departments of 1Epidemiology and Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina 57599, USA.

出版信息

J Infect Dis. 2010 Mar 15;201(6):946-55. doi: 10.1086/651022.

DOI:10.1086/651022
PMID:20144042
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2826557/
Abstract

BACKGROUND

Severe acute respiratory syndrome (SARS) emerged as a human disease in 2002. Detailed phylogenetic analysis and epidemiologic studies have suggested that the SARS coronavirus (SARS-CoV) originated from animals. The spike (S) glycoprotein has been identified as a major target of protective immunity and contains 3 regions that are targeted by neutralizing antibodies in the S1 and S2 domains. We previously characterized a panel of neutralizing human monoclonal antibodies (MAbs), but the majority of epitopes recognized by the MAbs remain unknown.

METHODS

In the present study, we generated neutralization escape mutants and studied the effect of these neutralization escape mutations on human and animal receptor usage as well as on in vitro and in vivo fitness.

RESULTS

Distinct but partially overlapping sets of amino acids were identified that are critical to the binding of MAbs with differential neutralization profiles. We also identified possible interactions between the S1 and S2 domains of the SARS-CoV S glycoprotein. Finally, we showed that escape from neutralization usually attenuates SARS-CoV infection.

CONCLUSIONS

These data provide a mechanism for overcoming neutralization escape by use of broadly cross-reactive cocktails of cross-neutralizing MAbs that recognize residues within the receptor-binding domain that are critical for virus replication and virulence.

摘要

背景

严重急性呼吸系统综合症(SARS)于 2002 年出现人类疾病。详细的系统发生分析和流行病学研究表明,SARS 冠状病毒(SARS-CoV)来源于动物。刺突(S)糖蛋白已被确定为保护性免疫的主要靶标,包含 3 个被 S1 和 S2 结构域中中和抗体靶向的区域。我们之前对一组中和性人单克隆抗体(MAb)进行了表征,但 MAb 识别的大多数表位仍然未知。

方法

在本研究中,我们生成了中和逃逸突变体,并研究了这些中和逃逸突变对人类和动物受体利用以及体外和体内适应性的影响。

结果

确定了截然不同但部分重叠的氨基酸集,这些氨基酸对具有不同中和特性的 MAb 的结合至关重要。我们还鉴定了 SARS-CoV S 糖蛋白的 S1 和 S2 结构域之间可能的相互作用。最后,我们表明,中和逃逸通常会减弱 SARS-CoV 的感染。

结论

这些数据提供了一种通过使用广泛交叉反应的中和性 MAb 鸡尾酒来克服中和逃逸的机制,这些 MAb 识别对病毒复制和毒力至关重要的受体结合域内的残基。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b093/7110002/5921888b9867/201-6-946-fig005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b093/7110002/7578f9a2fc2b/201-6-946-tab001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b093/7110002/990d9dd1a48d/201-6-946-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b093/7110002/cf13627d5c1a/201-6-946-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b093/7110002/38f215aaea03/201-6-946-fig003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b093/7110002/ea88014b5788/201-6-946-fig004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b093/7110002/5921888b9867/201-6-946-fig005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b093/7110002/7578f9a2fc2b/201-6-946-tab001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b093/7110002/990d9dd1a48d/201-6-946-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b093/7110002/cf13627d5c1a/201-6-946-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b093/7110002/38f215aaea03/201-6-946-fig003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b093/7110002/ea88014b5788/201-6-946-fig004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b093/7110002/5921888b9867/201-6-946-fig005.jpg

相似文献

1
Escape from human monoclonal antibody neutralization affects in vitro and in vivo fitness of severe acute respiratory syndrome coronavirus.逃避人源单克隆抗体中和作用影响严重急性呼吸综合征冠状病毒的体外和体内适应性。
J Infect Dis. 2010 Mar 15;201(6):946-55. doi: 10.1086/651022.
2
Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants.抗SARS冠状病毒的人源单克隆抗体组合:协同作用及对逃逸突变体的覆盖范围
PLoS Med. 2006 Jul;3(7):e237. doi: 10.1371/journal.pmed.0030237.
3
Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge.强效交叉中和性人单克隆抗体对致死性人类及人畜共患严重急性呼吸综合征冠状病毒攻击提供保护的结构基础。
J Virol. 2008 Apr;82(7):3220-35. doi: 10.1128/JVI.02377-07. Epub 2008 Jan 16.
4
Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies.严重急性呼吸综合征冠状病毒刺突蛋白的受体结合域包含多个构象依赖性表位,这些表位可诱导产生高效中和抗体。
J Immunol. 2005 Apr 15;174(8):4908-15. doi: 10.4049/jimmunol.174.8.4908.
5
Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness.人抗刺突蛋白受体结合域抗体对严重急性呼吸综合征冠状病毒中和逃逸及适应性的影响。
J Virol. 2014 Dec;88(23):13769-80. doi: 10.1128/JVI.02232-14. Epub 2014 Sep 17.
6
Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus.与严重急性呼吸综合征冠状病毒刺突蛋白和核衣壳蛋白结合的人单克隆抗体的分子和生物学特性
J Virol. 2005 Feb;79(3):1635-44. doi: 10.1128/JVI.79.3.1635-1644.2005.
7
A single amino acid substitution in the S1 and S2 Spike protein domains determines the neutralization escape phenotype of SARS-CoV.刺突蛋白S1和S2结构域中的单个氨基酸取代决定了SARS-CoV的中和逃逸表型。
Microbes Infect. 2008 Jul;10(8):908-15. doi: 10.1016/j.micinf.2008.05.009. Epub 2008 Jun 19.
8
Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design.重组杆状病毒表达的严重急性呼吸综合征冠状病毒刺突蛋白的抗原性和免疫原性特征:对疫苗设计的启示
J Virol. 2006 Jun;80(12):5757-67. doi: 10.1128/JVI.00083-06.
9
Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein.通过靶向刺突蛋白受体结合域的抗体对人及果子狸严重急性呼吸综合征冠状病毒进行交叉中和。
J Immunol. 2006 May 15;176(10):6085-92. doi: 10.4049/jimmunol.176.10.6085.
10
Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines.严重急性呼吸综合征(SARS)相关冠状病毒关键中和决定簇的鉴定:对设计SARS疫苗的重要性。
Virology. 2005 Mar 30;334(1):74-82. doi: 10.1016/j.virol.2005.01.034.

引用本文的文献

1
Deep learning for discriminating non-trivial conformational changes in molecular dynamics simulations of SARS-CoV-2 spike-ACE2.用于区分 SARS-CoV-2 刺突蛋白-ACE2 分子动力学模拟中非平凡构象变化的深度学习。
Sci Rep. 2024 Sep 30;14(1):22639. doi: 10.1038/s41598-024-72842-w.
2
Replication in the presence of dengue convalescent serum impacts Zika virus neutralization sensitivity and fitness.在登革热恢复期血清存在的情况下进行复制会影响寨卡病毒的中和敏感性和适应性。
Front Cell Infect Microbiol. 2023 Mar 9;13:1130749. doi: 10.3389/fcimb.2023.1130749. eCollection 2023.
3
SARS-CoV-2 variants resistant to monoclonal antibodies in immunocompromised patients constitute a public health concern.

本文引用的文献

1
Human monoclonal antibodies to SARS-coronavirus inhibit infection by different mechanisms.针对严重急性呼吸综合征冠状病毒的人源单克隆抗体通过不同机制抑制感染。
Virology. 2009 Nov 10;394(1):39-46. doi: 10.1016/j.virol.2009.07.028. Epub 2009 Sep 12.
2
Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection.急性呼吸窘迫综合征相关细胞因子的早期上调在严重急性呼吸综合征冠状病毒感染的老年小鼠模型中促进致死性疾病。
J Virol. 2009 Jul;83(14):7062-74. doi: 10.1128/JVI.00127-09. Epub 2009 May 6.
3
Structural insights into immune recognition of the severe acute respiratory syndrome coronavirus S protein receptor binding domain.
免疫功能低下患者中对单克隆抗体具有耐药性的 SARS-CoV-2 变异株引起了公共卫生关注。
J Clin Invest. 2023 Mar 15;133(6):e168603. doi: 10.1172/JCI168603.
4
Functional mutations of SARS-CoV-2: implications to viral transmission, pathogenicity and immune escape.SARS-CoV-2 的功能突变:对病毒传播、致病性和免疫逃逸的影响。
Chin Med J (Engl). 2022 May 20;135(10):1213-1222. doi: 10.1097/CM9.0000000000002158.
5
The Reassessed Potential of SARS-CoV-2 Attenuation for COVID-19 Vaccine Development-A Systematic Review.重新评估 SARS-CoV-2 减毒用于 COVID-19 疫苗开发的潜力——系统评价。
Viruses. 2022 May 7;14(5):991. doi: 10.3390/v14050991.
6
Insights into the evolutionary and prophylactic analysis of SARS-CoV-2: A review.对 SARS-CoV-2 的进化和预防分析的深入了解:综述。
J Virol Methods. 2022 Feb;300:114375. doi: 10.1016/j.jviromet.2021.114375. Epub 2021 Nov 24.
7
Identification and Development of Therapeutics for COVID-19.新型冠状病毒肺炎治疗方法的识别与开发
mSystems. 2021 Dec 21;6(6):e0023321. doi: 10.1128/mSystems.00233-21. Epub 2021 Nov 2.
8
Deep geometric representations for modeling effects of mutations on protein-protein binding affinity.用于模拟突变对蛋白质-蛋白质结合亲和力影响的深度几何表示。
PLoS Comput Biol. 2021 Aug 4;17(8):e1009284. doi: 10.1371/journal.pcbi.1009284. eCollection 2021 Aug.
9
Recent advances in antibody-based immunotherapy strategies for COVID-19.COVID-19 的抗体免疫疗法策略的最新进展。
J Cell Biochem. 2021 Oct;122(10):1389-1412. doi: 10.1002/jcb.30017. Epub 2021 Jun 23.
10
Structural basis for broad coronavirus neutralization.广谱冠状病毒中和的结构基础。
Nat Struct Mol Biol. 2021 Jun;28(6):478-486. doi: 10.1038/s41594-021-00596-4. Epub 2021 May 12.
严重急性呼吸综合征冠状病毒S蛋白受体结合域免疫识别的结构见解
J Mol Biol. 2009 May 15;388(4):815-23. doi: 10.1016/j.jmb.2009.03.042. Epub 2009 Mar 24.
4
Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway.拓宽中和活性以直接阻断主要抗体驱动的严重急性呼吸综合征冠状病毒进化途径。
PLoS Pathog. 2008 Nov;4(11):e1000197. doi: 10.1371/journal.ppat.1000197. Epub 2008 Nov 7.
5
Conserved amino acids W423 and N424 in receptor-binding domain of SARS-CoV are potential targets for therapeutic monoclonal antibody.严重急性呼吸综合征冠状病毒受体结合域中保守的氨基酸W423和N424是治疗性单克隆抗体的潜在靶点。
Virology. 2009 Jan 5;383(1):39-46. doi: 10.1016/j.virol.2008.09.029. Epub 2008 Nov 4.
6
A single amino acid substitution in the S1 and S2 Spike protein domains determines the neutralization escape phenotype of SARS-CoV.刺突蛋白S1和S2结构域中的单个氨基酸取代决定了SARS-CoV的中和逃逸表型。
Microbes Infect. 2008 Jul;10(8):908-15. doi: 10.1016/j.micinf.2008.05.009. Epub 2008 Jun 19.
7
Pathways of cross-species transmission of synthetically reconstructed zoonotic severe acute respiratory syndrome coronavirus.合成重建的人畜共患严重急性呼吸综合征冠状病毒的跨物种传播途径。
J Virol. 2008 Sep;82(17):8721-32. doi: 10.1128/JVI.00818-08. Epub 2008 Jun 25.
8
Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge.强效交叉中和性人单克隆抗体对致死性人类及人畜共患严重急性呼吸综合征冠状病毒攻击提供保护的结构基础。
J Virol. 2008 Apr;82(7):3220-35. doi: 10.1128/JVI.02377-07. Epub 2008 Jan 16.
9
Amino acid substitutions in the S2 subunit of mouse hepatitis virus variant V51 encode determinants of host range expansion.小鼠肝炎病毒V51变体S2亚基中的氨基酸取代编码宿主范围扩展的决定因素。
J Virol. 2008 Feb;82(3):1414-24. doi: 10.1128/JVI.01674-07. Epub 2007 Nov 21.
10
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies.人源单克隆抗体对严重急性呼吸综合征冠状病毒分离株的强效交叉反应中和作用。
Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12123-8. doi: 10.1073/pnas.0701000104. Epub 2007 Jul 9.